Skip to main content

Jennifer Altman

VP – IT Corporate Functions and Cyber Security

Jennifer Altman, IT Head of Corporate Functions and Cyber Security as well as IT Site Head at Roche headquarters in Switzerland, joined Roche after 15+ years of professional experience in consulting and industry. Since then, she has held a number of leadership positions with the global pharmaceutical and diagnostics giant, and the world's largest biotech company.

In this video she talks about:

  • Her career journey
  • Changes in the corporate environment for women leaders over the course of her career
  • Factors that drive her passion for a more diverse workforce, specifically in terms of women executives
  • How to become more aware of unconscious biases that inhibit diversity and inclusion
  • Advice she would give to young women who aspire to her level of success.

About Roche:

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI).